1. Home
  2. CMPS vs PSBD Comparison

CMPS vs PSBD Comparison

Compare CMPS & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • PSBD
  • Stock Information
  • Founded
  • CMPS 2020
  • PSBD 2009
  • Country
  • CMPS United Kingdom
  • PSBD United States
  • Employees
  • CMPS N/A
  • PSBD N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • PSBD
  • Sector
  • CMPS Health Care
  • PSBD
  • Exchange
  • CMPS Nasdaq
  • PSBD Nasdaq
  • Market Cap
  • CMPS 487.4M
  • PSBD 428.2M
  • IPO Year
  • CMPS 2020
  • PSBD 2024
  • Fundamental
  • Price
  • CMPS $6.34
  • PSBD N/A
  • Analyst Decision
  • CMPS Strong Buy
  • PSBD Hold
  • Analyst Count
  • CMPS 7
  • PSBD 4
  • Target Price
  • CMPS $17.00
  • PSBD $13.88
  • AVG Volume (30 Days)
  • CMPS 1.5M
  • PSBD 76.8K
  • Earning Date
  • CMPS 10-30-2025
  • PSBD 11-05-2025
  • Dividend Yield
  • CMPS N/A
  • PSBD 13.68%
  • EPS Growth
  • CMPS N/A
  • PSBD N/A
  • EPS
  • CMPS N/A
  • PSBD N/A
  • Revenue
  • CMPS N/A
  • PSBD N/A
  • Revenue This Year
  • CMPS N/A
  • PSBD N/A
  • Revenue Next Year
  • CMPS N/A
  • PSBD N/A
  • P/E Ratio
  • CMPS N/A
  • PSBD N/A
  • Revenue Growth
  • CMPS N/A
  • PSBD N/A
  • 52 Week Low
  • CMPS $2.25
  • PSBD $11.51
  • 52 Week High
  • CMPS $6.63
  • PSBD $16.32
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 73.27
  • PSBD 41.93
  • Support Level
  • CMPS $5.54
  • PSBD $12.07
  • Resistance Level
  • CMPS $6.62
  • PSBD $12.59
  • Average True Range (ATR)
  • CMPS 0.33
  • PSBD 0.39
  • MACD
  • CMPS 0.08
  • PSBD -0.01
  • Stochastic Oscillator
  • CMPS 86.39
  • PSBD 33.51

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: